Diabetes Mellitus

Scope & Guideline

Exploring the complexities of diabetes and its impact.

Introduction

Immerse yourself in the scholarly insights of Diabetes Mellitus with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageRussian
ISSN2072-0351
PublisherENDOCRINOLOGY RESEARCH CENTRE
Support Open AccessYes
CountryRussian Federation
TypeJournal
Convergefrom 2012 to 2024
AbbreviationDIABETES MELLIT / Diabetes Mellit.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressUL DMITRIYA UL YANOVA, D 11, MOSCOW 117036, RUSSIA

Aims and Scopes

The journal 'Diabetes Mellitus' focuses on the comprehensive study and management of diabetes and its complications, promoting research that spans clinical, epidemiological, and biochemical aspects of diabetes care. It aims to provide a platform for the dissemination of innovative research findings that can influence practice and improve patient outcomes.
  1. Clinical Management of Diabetes:
    Research focusing on the clinical management of diabetes, including pharmacological treatments, insulin therapy, and novel therapeutic approaches such as GLP-1 receptor agonists and SGLT2 inhibitors.
  2. Epidemiology and Public Health:
    Studies that analyze the prevalence, risk factors, and the epidemiological characteristics of diabetes and its complications within various populations.
  3. Biomarkers and Pathophysiology:
    Investigation into metabolic biomarkers, pathophysiological mechanisms, and their implications for the diagnosis and management of diabetes.
  4. Technological Innovations in Diabetes Care:
    Research on the latest advancements in diabetes technology, including continuous glucose monitoring systems and automated insulin delivery systems.
  5. Complications Associated with Diabetes:
    Studies examining the long-term complications of diabetes, such as cardiovascular diseases, nephropathy, neuropathy, and retinopathy.
  6. Lifestyle and Behavioral Aspects:
    Research addressing the impact of lifestyle factors, such as diet, physical activity, and psychological aspects on diabetes management and outcomes.
Recent publications in the journal 'Diabetes Mellitus' highlight several emerging themes that reflect current trends in diabetes research and management. These themes indicate a growing interest in innovative approaches and the integration of technology in diabetes care.
  1. Integration of Technology in Diabetes Care:
    There is an increasing focus on the use of technology, such as continuous glucose monitoring and automated insulin delivery systems, to enhance diabetes management and improve patient outcomes.
  2. Impact of COVID-19 on Diabetes:
    A significant rise in studies exploring the relationship between COVID-19 and diabetes, including how the pandemic has affected diabetes management and outcomes.
  3. Multidisciplinary Approaches to Diabetes Management:
    Emerging themes emphasize the importance of multidisciplinary care models, integrating insights from endocrinology, cardiology, nephrology, and nutrition to optimize diabetes management.
  4. Preventive Strategies and Early Intervention:
    Research is trending towards preventive strategies and early intervention methods to mitigate the onset of diabetes and its complications, particularly in high-risk populations.
  5. Psychosocial Aspects of Diabetes:
    There is a growing interest in the psychosocial impacts of diabetes, including mental health, quality of life, and patient education, indicating a broader understanding of diabetes management.

Declining or Waning

While the journal continues to cover a wide array of topics, some areas of research appear to be receiving less emphasis in recent publications. This reflects shifts in focus towards more pressing or emerging issues in diabetes care and management.
  1. Traditional Pharmacotherapy:
    There seems to be a decline in studies focused solely on traditional diabetes medications without considering newer therapies or combination treatments, indicating a shift towards more innovative approaches.
  2. Basic Science and Animal Studies:
    Research that is heavily based on basic science or animal models appears to be waning, with a stronger emphasis on clinical and translational research.
  3. Historical Perspectives on Diabetes Management:
    Research articles reflecting on historical perspectives or outdated practices in diabetes management are becoming less common, as the focus shifts to contemporary evidence-based practices.

Similar Journals

Journal of Diabetology

Advancing diabetes care through innovative research.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2543-3288Frequency: 3 issues/year

The Journal of Diabetology, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 2010, this Open Access journal has provided researchers and healthcare professionals with a wealth of knowledge through rigorous peer-reviewed articles that cover clinical research, epidemiology, and innovative treatment strategies. With an E-ISSN of 2078-7685 and a commitment to disseminating high-quality scientific work, the journal plays a pivotal role in contributing to the global discourse on diabetes care and prevention. Its dedication to accessibility enhances its impact on both established scholars and emerging researchers seeking to make meaningful contributions in the field. By fostering a collaborative environment, the Journal of Diabetology aims to bridge the gap between research and practical implementation, ultimately improving outcomes for individuals affected by diabetes.

Diabetes Technology & Therapeutics

Innovating Diabetes Care Through Technology and Research
Publisher: MARY ANN LIEBERT, INCISSN: 1520-9156Frequency: 12 issues/year

Diabetes Technology & Therapeutics is a leading journal published by MARY ANN LIEBERT, INC, dedicated to advancing the field of diabetes management through innovative technologies and therapeutic strategies. With an impressive impact factor and recognized as a Q1 journal in Endocrinology, Diabetes and Metabolism, as well as Medical Laboratory Technology, it occupies a pivotal position in the academic landscape. This esteemed publication features a comprehensive range of articles that cover cutting-edge research, clinical applications, and developments in diabetes care from 1999 to 2024, making it a critical resource for researchers, health professionals, and students alike. The journal is committed to fostering dialogue between disciplines, especially given its strong rankings in various scientific categories including the 98th percentile in Medical Laboratory Technology. By opting for subscription-based access, readers gain insight into the latest innovations that are shaping diabetes technology and treatment paradigms, thereby enhancing patient outcomes and advancing the scientific community's understanding of this complex disease.

Journal of Diabetes

Pioneering insights into diabetes pathophysiology and therapies.
Publisher: WILEYISSN: 1753-0393Frequency: 12 issues/year

The Journal of Diabetes, published by WILEY, is a premier Open Access platform since 2022, dedicated to advancing knowledge in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 1753-0393 and an E-ISSN of 1753-0407, this journal provides a vital resource for researchers and practitioners looking to keep up with the latest findings and trends in diabetes management and treatment. As of 2023, it holds a commendable Q2 rating in its category and ranks #78 out of 244 in the Scopus classification, placing it in the 68th percentile, thus affirming its significance in the academic community. Covering a timeline from 2009 to 2024, the journal invites submissions that contribute to the understanding of diabetes pathophysiology, innovative therapies, and clinical practices, making it an essential read for anyone dedicated to improving patient outcomes in diabetes care.

DIABETES CARE

Connecting research and practice in diabetes care.
Publisher: AMER DIABETES ASSOCISSN: 0149-5992Frequency: 12 issues/year

DIABETES CARE, published by the American Diabetes Association, is a premier journal dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 1978, this journal has maintained a commitment to disseminating high-quality research, evidenced by its prestigious ranking in the Q1 category across multiple fields including Advanced and Specialized Nursing, Endocrinology, Diabetes and Metabolism, and Internal Medicine. With an impressive impact factor and distinguished Scopus rankings, DIABETES CARE serves as an essential resource for researchers, clinicians, and students alike, facilitating the exchange of knowledge and fostering innovation in diabetes care. Although not an open-access publication, the journal offers various ways to access groundbreaking studies and advancements in the field. This commitment to excellence reflects the journal's vital role in shaping diabetes research and clinical practices globally.

International Journal of Diabetes in Developing Countries

Elevating diabetes understanding in the heart of India.
Publisher: SPRINGER INDIAISSN: 0973-3930Frequency: 4 issues/year

The International Journal of Diabetes in Developing Countries, published by SPRINGER INDIA, stands as a pivotal resource in the field of diabetes research, particularly focusing on the challenges and advancements in diabetes management within developing nations. With an ISSN of 0973-3930 and an E-ISSN of 1998-3832, this journal has been fostering knowledge exchange since its inception in 2001, converging its focus over multiple years to maintain relevance through 2024. As a peer-reviewed journal, it holds a significant position within the Q4 category of Endocrinology, Diabetes and Metabolism and Q3 in Internal Medicine, showcasing its commitment to addressing critical issues regarding diabetes care in diverse populations. The journal is crucial for researchers, healthcare professionals, and students seeking to further their understanding of diabetes in resource-limited settings. Although it operates without an open access model, the journal ensures rigorous peer review, maintaining high academic standards that benefit the growing field of diabetes research. With its address located in the heart of New Delhi, India, this publication serves as a vital repository for valuable insights and innovative strategies aimed at combating diabetes in developing countries.

DIABETES

Elevating standards, inspiring breakthroughs in diabetes research.
Publisher: AMER DIABETES ASSOCISSN: 0012-1797Frequency: 12 issues/year

DIABETES, published by the American Diabetes Association, is a premier journal in the field of endocrinology, diabetes, and metabolism, renowned for its rigorous peer-reviewed research since its inception in 1952. With an impressive impact factor and classified in the Q1 category for both Endocrinology, Diabetes and Metabolism and Internal Medicine as of 2023, it holds a prestigious position within the scholarly community, ranked 17th out of 244 in its specialization. The journal's objective is to disseminate cutting-edge research and advance scientific understanding to ultimately improve diabetes patient care and management. While it does not offer open access options, the journal remains a vital resource for researchers, professionals, and students involved in diabetes-related studies. The ongoing dedication to excellence by the authors, reviewers, and editors ensures that DIABETES continues to be a pivotal platform for innovation and knowledge in the fight against diabetes.

JOURNAL OF DIABETES AND ITS COMPLICATIONS

Bridging gaps in diabetes knowledge for improved outcomes.
Publisher: ELSEVIER SCIENCE INCISSN: 1056-8727Frequency: 6 issues/year

JOURNAL OF DIABETES AND ITS COMPLICATIONS is a distinguished peer-reviewed journal published by Elsevier Science Inc, dedicated to advancing the knowledge and management of diabetes and its multifaceted complications. With an ISSN of 1056-8727 and E-ISSN 1873-460X, this journal has established its significance in the fields of Endocrinology, Diabetes and Metabolism, and Internal Medicine, as reflected in its Q2 and Q1 quartile rankings for 2023, and its commendable Scopus rankings. The journal, which has been converging knowledge since 1992 and continues to publish vital research until 2024, serves as a platform for researchers, professionals, and students aiming to delve deeper into the mechanisms, treatment, and implications of diabetes and its related disorders. While access is not open, the journal remains a critical resource for those invested in understanding and combating the challenges posed by diabetes, ultimately contributing to better health outcomes.

Journal of Diabetes and Metabolic Disorders

Advancing Diabetes Research for a Healthier Tomorrow
Publisher: SPRINGER INT PUBL AGISSN: Frequency:

The Journal of Diabetes and Metabolic Disorders, published by SPRINGER INT PUBL AG, is a premier academic journal dedicated to advancing research in the fields of endocrinology, diabetes, and metabolism. With an E-ISSN of 2251-6581, this journal plays a crucial role in disseminating high-quality research findings from 2012 to 2024, serving as a valuable resource for researchers, practitioners, and students alike. Notably, it has achieved impressive rankings, being placed in the Q2 quartile for Internal Medicine and Q3 for Endocrinology, Diabetes, and Metabolism in 2023, reflecting its influence within the scientific community. The Journal’s commitment to open access ensures that its comprehensive articles, encompassing topics from metabolic disorders to novel therapeutic approaches, are readily available to a global audience. Position yourself at the forefront of medical advancements—contribute to and benefit from the pivotal research presented in this journal.

British Journal of Diabetes

Advancing diabetes care through innovative research.
Publisher: ASSOC BRITISH CLINICAL DIABETOLOGISTSISSN: 2397-6233Frequency: 2 issues/year

The British Journal of Diabetes, published by the Association of British Clinical Diabetologists, is a premier journal dedicated to advancing the understanding, prevention, and management of diabetes. With an ISSN of 2397-6233, this journal aims to disseminate high-quality research findings, clinical studies, and reviews that address the complexities of diabetes care and research. While currently not available as an open access option, the journal is committed to enhancing the visibility of cutting-edge diabetes research for healthcare professionals and academics. Located in the heart of England, this journal plays a crucial role in bridging the gap between clinical practice and research innovation, making it an essential resource for practitioners, researchers, and students alike. The British Journal of Diabetes is determined to contribute significantly to the global dialogue on diabetes, as it covers a wide spectrum of topics from epidemiology and public health to novel therapeutic strategies and patient management approaches.

DIABETOLOGIA

Elevating knowledge in diabetes management and treatment.
Publisher: SPRINGERISSN: 0012-186XFrequency: 12 issues/year

DIABETOLOGIA is a leading journal in the field of endocrinology and diabetes research, published by Springer since its inception in 1965. With an impactful presence in both Internal Medicine and Endocrinology, Diabetes and Metabolism, it is recognized in the Q1 quartile rankings for 2023, underscoring its significance and contribution to these disciplines. The journal holds impressive Scopus rankings, placing it in the top 5% of journals in its categories, making it an essential resource for researchers, healthcare professionals, and students dedicated to advancing knowledge and practices in diabetes care and management. DIABETOLOGIA publishes a range of peer-reviewed articles, original research, and reviews that address the latest scientific developments, clinical practices, and therapeutic innovations, contributing to the global discourse on diabetes and its related health implications. Although it does not offer Open Access options, its rigorous selection process guarantees the quality and relevance of the content, solidifying its position as a reliable reference for contemporary research. For those looking to stay at the forefront of diabetes science, DIABETOLOGIA is a vital communique in the ever-evolving landscape of medical research.